市場調查報告書
商品編碼
1410102
防腐劑和消毒劑市場:2023-2028 年預測Antiseptic and Disinfectant Market - Forecasts from 2023 to 2028 |
防腐劑和消毒劑市場預計在預測期內複合年成長率為 12.38%。
防腐劑廣泛用於醫療機構的局部和硬表面應用。與抗生素相比,這些活性化合物大多具有廣譜抗菌活性,但對其作用方式知之甚少。由於防腐劑和消毒劑的廣泛使用,關於微生物抗藥性的出現存在很大爭議,特別是抗菌素抗藥性是否是由防腐劑或消毒劑介導的。
感染疾病引起的疾病增加是防腐劑和消毒劑市場的主要成長動力。隨著世界各地的人們越來越容易感染疾病引起的疾病,人們必須採取預防措施。行業巨頭的廣泛研究和開發計劃正在推動防腐劑和消毒劑的市場佔有率。這些製造商增加投資也是防腐劑和消毒劑市場成長的關鍵因素。
防腐劑和消毒劑市場擴張的關鍵促進因素之一是由於缺乏衛生和安全措施而導致的醫院感染增加。例如,在醫療保健相關感染中,據估計,每年入院的患者中大約有二分之一至少發生一次醫院感染。防腐劑和消毒劑在整體污染、預防和減少 HAI 頻率方面發揮重要作用。防腐消毒劑產品進一步促進了防腐消毒劑市場的發展,因為它們可以保護患者的身體免受所有細菌和微生物的感染。
保險公司向客戶提供許多有吸引力的報銷計劃,幫助他們選擇尖端的治療技術,從而促進防腐劑和消毒劑市場的成長。儘管可支配收入較低,但仍鼓勵採取報銷策略,為這些族群提供治療選擇。隨著受感染疾病影響的人數增加,核准的報銷數量也增加。
稱為表面消毒劑的化學物質用於殺死或惰性惰性表面上的細菌。這些消毒劑透過破壞微生物的細胞壁或抑制其新陳代謝來發揮作用。透過徹底的表面清洗,也可以避免患者入院時不存在或潛伏的感染疾病。表面消毒劑包括用於不同目的的化學物質。根據世界衛生組織 (WHO) 2022 年 3 月更新的資料,在非醫療保健環境中,使用建議劑量為 0.1% 或 1,000 ppm 的次氯酸鈉(漂白劑/氯)即可。 70-90% 濃度的酒精也可用於消毒表面。
手術設備和內視鏡通常使用醫療設備消毒劑再處理。苯酚、過氧化氫、過氧乙酸和戊二醛是用於醫療設備再處理和消毒的一些消毒劑。內視鏡和醫療設備需要消毒,因為有透過皮膚接觸在患者之間傳播感染的風險。全球外科手術數量的增加也是推動防腐消毒劑市場成長的主要因素之一。
酒精類消毒劑因其能有效消除多種細菌而被用於臨床設備。它易於使用且無毒,使其成為醫療應用的理想選擇。消毒內視鏡是臨床器械的主要用途之一。內視鏡通常使用酒精類消毒劑消毒和清洗。酒精消毒劑可有效殺死許多病菌,包括真菌、細菌和病毒。因此,醫療設備對酒精類消毒劑的需求不斷成長可能會推動防腐劑和消毒劑市場的擴張。
預計北美將成為防腐劑和消毒劑市場的股份持有人。隨著北美醫護人員和手術數量的增加,預計北美對消毒劑和防腐劑的需求將會增加。防腐劑和消毒劑對於外科手術和科學研究至關重要,因為它們可以最大限度地降低患者之間感染和污染的風險。此外,由於醫院感染發生率增加以及醫生處方感染療法的調整,該地區正在經歷成長。
防腐消毒劑製造商根據各種職業危害所需的防護等級,利用新穎、尖端的技術來生產和銷售產品給不同的終端消費者,這對於擴大防腐消毒劑的市場佔有率至關重要。例如,2021 年 1 月,加拿大衛生署在其有效對抗 SARS-CoV-2 的消毒劑清單中添加了五種莊臣家用清洗產品。這些消毒劑經莊臣批准可消滅 SARS-CoV-2,這種病毒在摩擦時會導致泡沫狀的 COVID-19 症狀。因此,由於許多公司之前和正在進行的開發,COVID-19 大流行產生了積極的商業性影響。
2022 年 10 月,Deepak Fertilizers And Petrochemicals Corporation (DFPCL) 推出了 Cororid 消毒產品,以滿足醫院、診所、實驗室和其他醫療保健設施的獨特需求。 2022年9月,利潔時及其品牌滴露將加入配送服務和本地旅遊領域的領導者Deliveroo,透過可見消毒劑提高其服務的衛生標準,保障香港居民的日常需求。宣布與、順豐速運、和優步。 2022 年 8 月,PDI 宣布推出獨特且創新的消毒劑,以協助感染預防專業人員持續對抗 COVID-19 和日益增加的醫療相關感染疾病(HAI)。
The antiseptic and disinfectant market is estimated to grow at a CAGR of 12.38% during the forecast period.
Antiseptics are used in healthcare facilities for a wide range of topical and hard-surface applications. In contrast to antibiotics, the majority of these active compounds have broad-spectrum antimicrobial activity, although little is known about their method of action. Since antiseptics and disinfectants are used widely, there has been significant discussion over the emergence of microbial resistance, particularly about whether antimicrobial resistance is brought on by antiseptics or disinfectants.
Rising instances of illness caused due to infections are a major growth driver for the antiseptic and disinfectant market. Precautions must be taken by people as the population around the world is prone to illness caused by infections. Extensive R&D programs are being carried out by industry leaders to manufacture new and improved products which is propelling the antiseptic and disinfectant market share. The growing investment by these manufacturers has also emerged as a crucial factor for the antiseptic and disinfectant market growth.
One of the main drivers of antiseptic and disinfectant market expansion is the rising prevalence of HAIs brought on by a lack of sanitation and safety measures. For instance, Healthcare-Associated Infections estimated that at least one HAI is required annually by approximately one in every twenty-five patients present in the hospital. Antiseptics and disinfectants play a significant role in overall contamination, prevention and lowering the frequency of HAIs. Antiseptic and disinfectant products protect the patient's body from any bacterial and microbial infections, which is further propelling the antiseptic and disinfectant market.
Many attractive reimbursement plans are being offered by insurance firms to customers that would help them select cutting-edge technologies for treatment leading to antiseptic and disinfectant market growth. Reimbursement strategies are encouraged to make treatment options accessible for these people despite their low disposable income. As the number of people suffering from infectious illness increases the number of reimbursements that are being authorized also increases.
Chemical substances known as surface disinfectants are used to kill or render inactive bacteria on inert surfaces. These disinfectants function by rupturing microorganisms' cell walls or obstructing their metabolism. Infections that do not exist or are not incubating at the time a patient is admitted can be avoided by performing thorough surface cleaning. Surface disinfectants utilize several chemicals for various objectives. In non-healthcare contexts, sodium hypochlorite (bleach/chlorine) may be used at a recommended dosage of 0.1% or 1,000 ppm, according to World Health Organisation (WHO) data revised in March 2022. Also useful for surface sanitation is alcohol at 70-90% concentration.
Surgical units and endoscopes are often reprocessed using medical equipment disinfectants. Phenol, hydrogen peroxide, peracetic acid, and glutaraldehyde are some of the disinfectants used for reprocessing or disinfecting medical devices. The risk of infection spreading from patient to patient due to skin contact is the reason why endoscopes and medical devices need to be disinfected. The rising number of surgical operations being performed globally is one of the primary factors propelling the antiseptic and disinfectant market growth.
Alcohol-based disinfectants are utilized on clinical instruments due to their effectiveness in eliminating a wide variety of bacteria. They are ideal for medical applications because they are also simple to use and non-toxic. Disinfecting endoscopes is one of the main uses for clinical equipment. Endoscopes are often sterilized and cleaned using alcohol-based disinfectants. They efficiently eradicate many germs, including fungi, bacteria, and viruses. Thus, the growing need for alcohol-based disinfectants for medical equipment will probably promote antiseptic and disinfectant market expansion.
North America is predicted to be the leading antiseptic and disinfectant market shareholder due to the increasing number of healthcare personnel working in North America and the growing number of operations, the demand for disinfectants and antiseptics in the region is anticipated to increase. Antiseptic and disinfection treatments are crucial for surgical procedures and scientific research because they minimize the danger of infection and contamination transferring from one patient to another. Furthermore, the region is experiencing growth due to a rise in the incidence of hospital-acquired infections and the adaption of doctor-prescribed infection therapies.
Based on the level of protection necessary for various occupational hazards, antiseptics and disinfectant manufacturing businesses utilize novel and cutting-edge technologies to create, manufacture, and distribute goods to a variety of end consumers which is crucial in the expansion of antiseptic and disinfectant market share. For instance, Health Canada added five SC Johnson household cleaning products to its list of effective disinfectants for use against SARS-CoV-2 in January 2021. These disinfectants have been authorized by SC Johnson to destroy SARS-CoV-2, the virus that generates COVID-19 symptoms like bubbles when you scrub. The COVID-19 pandemic, therefore, had a favourable commercial impact as a result of previous and ongoing developments made by numerous firms.